查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2049580

藥物發現資訊學市場報告：按工作流程、功能、方法、最終用戶和地區分類（2026-2034 年）

Drug Discovery Informatics Market Report by Workflow, Function, Mode, End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization, and Others), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

2025年全球藥物發現資訊學市場規模達39.7億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到84.4億美元，2026年至2034年的複合年成長率為8.48%。

藥物資訊學是一套用於分析和解讀大量生化數據的技術解決方案。這些數據來自臨床檢查室進行的科研實驗，旨在為各種藥物的研發提供重要資訊。它涵蓋了眾多軟硬體工具，用於藥物發現和研發過程中的定序、標靶資料分析、資料視覺化、分子對接、分子建模和資料庫保護。因此，它被醫療機構、製藥和生物技術公司以及合約研究組織（CRO）廣泛應用。

全球醫療保健和製藥行業的顯著成長是推動該市場前景光明的重要因素之一。此外，慢性病盛行率的不斷上升以及對治療罕見疾病的有效方案日益成長的需求也在推動市場成長。藥物資訊學被製藥公司廣泛用於分析候選藥物和處理來自多個資訊來源的生物資訊。此外，各種技術進步，例如開發創新的生理藥物動力學 (PBPK) 模擬平台，透過建模和模擬預測藥物動力學結果，也在推動市場成長。因此，政府和私人醫療機構對孤兒藥研發投入的增加也促進了市場成長。人口老化以及生物資訊學領域廣泛的研發活動等其他因素預計也將進一步推動市場發展。

本報告解答的主要問題

  • 全球藥物發現資訊學市場目前的發展狀況如何？未來幾年預計會如何發展？
  • 新冠疫情對全球藥物研發資訊學市場產生了哪些影響？
  • 主要區域市場有哪些？
  • 根據工作流程，市場區隔如何？
  • 依功能分類，市場組成是怎樣的？
  • 以配送方式分類的市場區隔如何？
  • 依最終用戶分類的市場區隔如何？
  • 該產業價值鏈包含哪些不同階段？
  • 該行業的主要促進因素和挑戰是什麼？
  • 全球藥物發現資訊學市場的結構是怎麼樣的？主要參與者有哪些？
  • 這個行業的競爭有多激烈？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球藥物發現資訊學市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依工作流程

  • 藥物發現
  • 藥物研發

第7章 市場區隔：依功能分類

  • 序列分析平台
  • 分子建模
  • 分子對接
  • 臨床試驗數據管理
  • 其他

第8章 市場區隔：依模式

  • 外包
  • 內部

第9章 市場區隔：依最終用戶分類

  • 製藥公司
  • 生技公司
  • CRO（藥物研發合約研究組織）
  • 其他

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Accenture PLC
    • Certara
    • Charles River Laboratories Inc.
    • Collaborative Drug Discovery Inc.
    • Eurofins DiscoverX Products
    • Infosys Ltd.
    • International Business Machines Corporation
    • Jubilant Biosys Limited
    • Oracle Corporation
    • PerkinElmer Inc.
    • Selvita
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A3515

The global drug discovery informatics market size reached USD 3.97 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 8.44 Billion by 2034, exhibiting a growth rate (CAGR) of 8.48% during 2026-2034.

Drug discovery informatics is a technological solution used for analyzing and interpreting large volumes of biochemical data. The data is generated from the experiments conducted in clinical laboratories for research purposes and utilized for generating insights regarding the development of various drugs. It involves numerous software and hardware-based tools for sequencing, target data analysis, data visualization, docking, molecular modelling, database protection for drug discovery and development. As a result, it is widely used by healthcare institutions, pharmaceutical and biotechnology organizations and contract research organizations (CROs).

Significant growth in the healthcare and pharmaceutical industries across the globe represents one of key the factors creating a positive outlook for the market. Furthermore, the increasing prevalence of chronic medical disorders and the escalating requirement for effective solutions to treat rare diseases are also augmenting the market growth. Drug discovery informatics is widely used by pharmaceutical organizations for the analysis of new drug entities and handling of the biological information from multiple sources. Additionally, various technological advancements, such as the development of innovative Physiologically-based Pharmacokinetic (PBPK) Simulator platforms, which aid in predicting pharmacokinetic outcomes through modeling and simulation, are acting as other growth-inducing factors. In line with this, increasing investments by government and private healthcare institutions to develop orphan drugs is also contributing to the market growth. Other factors, including the rising geriatric population, along with extensive research and development (R&D) activities in the field of bioinformatics, are anticipated to drive the market further.

KEY MARKET SEGMENTATION:

Breakup by Workflow:

  • Drug Discovery
  • Drug Development

Breakup by Function:

  • Sequence Analysis Platforms
  • Molecular Modelling
  • Molecular Docking
  • Clinical Trial Data Management
  • Others

Breakup by Mode:

  • Outsourced
  • In-house

Breakup by End User:

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organization (CROs)
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

COMPETITIVE LANDSCAPE:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Accenture Plc, Certara, Charles River Laboratories Inc., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products, Infosys Ltd., International Business Machines Corporation, Jubilant Biosys Limited, Oracle Corporation, PerkinElmer Inc., Selvita and Thermo Fisher Scientific Inc.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the global drug discovery informatics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global drug discovery informatics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the workflow?
  • What is the breakup of the market based on the function?
  • What is the breakup of the market based on the mode?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global drug discovery informatics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Drug Discovery Informatics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Workflow

  • 6.1 Drug Discovery
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Drug Development
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Function

  • 7.1 Sequence Analysis Platforms
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Molecular Modelling
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Molecular Docking
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Clinical Trial Data Management
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Mode

  • 8.1 Outsourced
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 In-house
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pharmaceutical Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Biotechnology Companies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Contract Research Organization (CROs)
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Accenture PLC
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Certara
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Charles River Laboratories Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Collaborative Drug Discovery Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Eurofins DiscoverX Products
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Infosys Ltd.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 International Business Machines Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Jubilant Biosys Limited
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Oracle Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 PerkinElmer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Selvita
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Drug Discovery Informatics Market: Major Drivers and Challenges
  • Figure 2: Global: Drug Discovery Informatics Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Drug Discovery Informatics Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Drug Discovery Informatics Market: Breakup by Workflow (in %), 2025
  • Figure 5: Global: Drug Discovery Informatics Market: Breakup by Function (in %), 2025
  • Figure 6: Global: Drug Discovery Informatics Market: Breakup by Mode (in %), 2025
  • Figure 7: Global: Drug Discovery Informatics Market: Breakup by End User (in %), 2025
  • Figure 8: Global: Drug Discovery Informatics Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Drug Discovery Informatics (Drug Discovery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Drug Discovery Informatics (Drug Discovery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Drug Discovery Informatics (Drug Development) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Drug Discovery Informatics (Drug Development) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Drug Discovery Informatics (Sequence Analysis Platforms) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Drug Discovery Informatics (Sequence Analysis Platforms) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Drug Discovery Informatics (Molecular Modelling) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Drug Discovery Informatics (Molecular Modelling) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Drug Discovery Informatics (Molecular Docking) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Drug Discovery Informatics (Molecular Docking) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Drug Discovery Informatics (Clinical Trial Data Management) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Drug Discovery Informatics (Clinical Trial Data Management) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Drug Discovery Informatics (Other Functions) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Drug Discovery Informatics (Other Functions) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Drug Discovery Informatics (Outsourced) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Drug Discovery Informatics (Outsourced) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Drug Discovery Informatics (In-house) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Drug Discovery Informatics (In-house) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Drug Discovery Informatics (Pharmaceutical Companies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Drug Discovery Informatics (Pharmaceutical Companies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Drug Discovery Informatics (Biotechnology Companies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Drug Discovery Informatics (Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Drug Discovery Informatics (Contract Research Organization (CROs)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Drug Discovery Informatics (Contract Research Organization (CROs)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Drug Discovery Informatics (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Drug Discovery Informatics (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: North America: Drug Discovery Informatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: North America: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: United States: Drug Discovery Informatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: United States: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Canada: Drug Discovery Informatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Canada: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Asia-Pacific: Drug Discovery Informatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Asia-Pacific: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: China: Drug Discovery Informatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: China: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Japan: Drug Discovery Informatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Japan: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: India: Drug Discovery Informatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: India: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: South Korea: Drug Discovery Informatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: South Korea: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Australia: Drug Discovery Informatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Australia: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Indonesia: Drug Discovery Informatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Indonesia: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Others: Drug Discovery Informatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Others: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Europe: Drug Discovery Informatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Europe: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Germany: Drug Discovery Informatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Germany: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: France: Drug Discovery Informatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: France: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: United Kingdom: Drug Discovery Informatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: United Kingdom: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Italy: Drug Discovery Informatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Italy: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Spain: Drug Discovery Informatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Spain: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Russia: Drug Discovery Informatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Russia: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Others: Drug Discovery Informatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Others: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Latin America: Drug Discovery Informatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Latin America: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Brazil: Drug Discovery Informatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Brazil: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Mexico: Drug Discovery Informatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Mexico: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Others: Drug Discovery Informatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Others: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Middle East and Africa: Drug Discovery Informatics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: Middle East and Africa: Drug Discovery Informatics Market: Breakup by Country (in %), 2025
  • Figure 83: Middle East and Africa: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Global: Drug Discovery Informatics Industry: SWOT Analysis
  • Figure 85: Global: Drug Discovery Informatics Industry: Value Chain Analysis
  • Figure 86: Global: Drug Discovery Informatics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Drug Discovery Informatics Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Drug Discovery Informatics Market Forecast: Breakup by Workflow (in Million USD), 2026-2034
  • Table 3: Global: Drug Discovery Informatics Market Forecast: Breakup by Function (in Million USD), 2026-2034
  • Table 4: Global: Drug Discovery Informatics Market Forecast: Breakup by Mode (in Million USD), 2026-2034
  • Table 5: Global: Drug Discovery Informatics Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 6: Global: Drug Discovery Informatics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Drug Discovery Informatics Market: Competitive Structure
  • Table 8: Global: Drug Discovery Informatics Market: Key Players